These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 652125)

  • 1. Effect of ventriculo-cisternal perfusion with angiotensin II and indomethacin on the plasma vasopressin concentration.
    Yamamoto M; Share L; Shade RE
    Neuroendocrinology; 1978; 25(3):166-73. PubMed ID: 652125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasopressin release during ventriculo-cisternal perfusion with prostaglandin E2 in the dog.
    Yamamoto M; Share L; Shade RE
    J Endocrinol; 1976 Dec; 71(3):325-31. PubMed ID: 1003062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central indomethacin enhances volume-dependent vasopressin release.
    Brooks DP; Share L; Crofton JT; Nasjletti A
    Am J Physiol; 1984 Dec; 247(6 Pt 2):R1017-21. PubMed ID: 6391207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin release during nonhypotensive hemorrhage and angiotensin II infusion.
    Shade RE; Share L
    Am J Physiol; 1975 Jan; 228(1):149-54. PubMed ID: 1147005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intracerebroventricular indomethacin on osmotically stimulated vasopressin release.
    Hoffman PK; Share L; Crofton JT; Shade RE
    Neuroendocrinology; 1982 Feb; 34(2):132-9. PubMed ID: 7070586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central action of angiotensin in stimulating ADH release.
    Mouw D; Bonjour JP; Malvin RL; Vander A
    Am J Physiol; 1971 Jan; 220(1):239-42. PubMed ID: 4321203
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between the renin-angiotensin system and vasopressin in the control of extracellular fluid volume.
    Share L
    JPEN J Parenter Enteral Nutr; 1980; 4(2):77-82. PubMed ID: 6995631
    [No Abstract]   [Full Text] [Related]  

  • 8. Angiotensin II and norepinephrine after indomethacin in isolated perfused canine kidneys. Tachyphylaxis vs. modulator effect of prostaglandins.
    Ellis B; Itskovitz HD
    Prostaglandins; 1980 Dec; 20(6):981-91. PubMed ID: 7010451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation for roles of periventricular cholinoceptors in vasopressin secretion in response to angiotensin II and an osmotic stimulus.
    Yamaguchi K; Hama H
    Brain Res; 1989 Sep; 496(1-2):345-50. PubMed ID: 2804646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of intracerebral angiotensin receptors in the regulation of vasopressin release and the cardiovascular system.
    Shoji M; Kimura T; Matsui K; Ota K; Iitake K; Inoue M; Yoshinaga K
    Neuroendocrinology; 1986; 43(2):239-44. PubMed ID: 3014365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of suppression of plasma renin activity by centrally administered angiotensin II.
    Malayan SA; Keil LC; Ramsay DJ; Reid IA
    Endocrinology; 1979 Mar; 104(3):672-5. PubMed ID: 436726
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of angiotensin II on plasma antidiuretic hormone and renal water excretion.
    Henrich WL; Walker BR; Handelman WA; Erickson AL; Arnold PE; Schrier RW
    Kidney Int; 1986 Oct; 30(4):503-8. PubMed ID: 3784290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation by angiotensin II of the vasopressin response to an increasing plasma osmolality.
    Shimizu K; Share L; Claybaugh JR
    Endocrinology; 1973 Jul; 93(1):42-50. PubMed ID: 4351317
    [No Abstract]   [Full Text] [Related]  

  • 14. Circulatory and respiratory effects evoked by hypertonic ventriculo-cisternal perfusion.
    Mellander S; Hillman J
    Acta Physiol Scand; 1975 Jun; 94(2):229-35. PubMed ID: 1174005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profile of circulating vasoactive substances in hemorrhagic shock and their pharmacologic manipulation.
    Jakschik BA; Marshall GR; Kourik JL; Needleman P
    J Clin Invest; 1974 Oct; 54(4):842-52. PubMed ID: 4372250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dilatation by angiotensin II of the rat femoral arterial bed in vivo via pressure/flow-induced release of nitric oxide and prostaglandins.
    Heinemann A; Wachter CH; Peskar BA; Holzer P
    Br J Pharmacol; 1997 Nov; 122(6):975-84. PubMed ID: 9401758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Angiotensin II infusion increases vasopressin, ACTH, and 11-hydroxycorticosteroid secretion.
    Ramsay DJ; Keil LC; Sharpe MC; Shinsako J
    Am J Physiol; 1978 Jan; 234(1):R66-71. PubMed ID: 203199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of angiotensin II on renal water excretion.
    Cadnapaphornchai P; Boykin J; Harbottle JA; McDonald KM; Schrier RW
    Am J Physiol; 1975 Jan; 228(1):155-9. PubMed ID: 1147006
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of angiotensin II- and III-induced aldosterone release by prostaglandin synthesis inhibitors.
    Campbell WB; Gomez-Sanchez CE; Adams BV; Schmitz JM; Itskovitz HD
    J Clin Invest; 1979 Dec; 64(6):1552-7. PubMed ID: 500824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of angiotensin II on plasma ADH, prostaglandin synthesis, and water excretion in normal humans.
    Usberti M; Federico S; Di Minno G; Ungaro B; Ardillo G; Pecoraro C; Cianciaruso B; Cerbone AM; Cirillo F; Pannain M
    Am J Physiol; 1985 Feb; 248(2 Pt 2):F254-9. PubMed ID: 3881995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.